128 related articles for article (PubMed ID: 11380406)
21. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
[TBL] [Abstract][Full Text] [Related]
22. CLL family 'Pedigree 14' revisited: 1947-2004.
Jønsson V; Houlston RS; Catovsky D; Yuille MR; Hilden J; Olsen JH; Fajber M; Brandt B; Sellick G; Allinson R; Wiik A
Leukemia; 2005 Jun; 19(6):1025-8. PubMed ID: 15800670
[TBL] [Abstract][Full Text] [Related]
23. Familial Hodgkin's lymphoma in Scandinavia.
Jønsson V; Awan H; Nyquist E; Maisenhølder M; Johannesen TB; Ly B; Tjønnfjord GE
In Vivo; 2011; 25(3):431-7. PubMed ID: 21576419
[TBL] [Abstract][Full Text] [Related]
24. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.
Abel GA; Bertrand KA; Earle CC; Laden F
Hematol Oncol; 2010 Sep; 28(3):133-6. PubMed ID: 19866451
[TBL] [Abstract][Full Text] [Related]
25. Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.
Rumi E; Passamonti F; Della Porta MG; Elena C; Arcaini L; Vanelli L; Del Curto C; Pietra D; Boveri E; Pascutto C; Cazzola M; Lazzarino M
J Clin Oncol; 2007 Dec; 25(35):5630-5. PubMed ID: 17998545
[TBL] [Abstract][Full Text] [Related]
26. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
[TBL] [Abstract][Full Text] [Related]
27. Familial chronic lymphocytic leukemia: what does it mean to me?
Slager SL; Kay NE
Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S194-7. PubMed ID: 19778840
[TBL] [Abstract][Full Text] [Related]
28. Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees.
Wiernik PH; Wickramasinghe D; Dutcher JP
Clin Adv Hematol Oncol; 2015 Apr; 13(4):257-60. PubMed ID: 26352584
[TBL] [Abstract][Full Text] [Related]
29. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden.
Shugart YY; Hemminki K; Vaittinen P; Kingman A; Dong C
Hum Genet; 2000 May; 106(5):553-6. PubMed ID: 10914686
[TBL] [Abstract][Full Text] [Related]
30. Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
Goldin LR; Caporaso NE
Br J Haematol; 2007 Dec; 139(5):774-9. PubMed ID: 18021091
[TBL] [Abstract][Full Text] [Related]
31. Familial chronic lymphocytic leukemia in Israel: A disproportionate distribution among Ashkenazi Jews.
Zada M; Lerner D; Piltz Y; Perry C; Avivi I; Herishanu Y
Eur J Haematol; 2017 Jul; 99(1):51-55. PubMed ID: 28370385
[TBL] [Abstract][Full Text] [Related]
32. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
33. Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M.
Lemos C; Coelho T; Alves-Ferreira M; Martins-da-Silva A; Sequeiros J; Mendonça D; Sousa A
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):326-30. PubMed ID: 24046394
[TBL] [Abstract][Full Text] [Related]
34. Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.
Wiernik PH; Dutcher JP
J Investig Med; 2024 Jan; 72(1):26-31. PubMed ID: 37864488
[TBL] [Abstract][Full Text] [Related]
35. Familial occurrence of chronic lymphocytic leukaemia in Norway.
Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
[TBL] [Abstract][Full Text] [Related]
36. Anticipation in familial cavernous angioma: ascertainment bias or genetic cause.
Siegel AM; Andermann F; Badhwar A; Rouleau GA; Dam M; Hopf HC; Dichgans J; Sturzenegger M; Hopf NJ; Yasui N; Stepper F; Killer M; Vanneste JA; Acciarri N; Drigo P; Christensen J; Braun V; Könü D; Andermann E
Acta Neurol Scand; 1998 Dec; 98(6):372-6. PubMed ID: 9875613
[TBL] [Abstract][Full Text] [Related]
37. Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.
Awan H; Jønsson V; Johannesen TB; Ly B; Tjønnfjord GE
Transl Oncogenomics; 2010 Mar; 4():1-9. PubMed ID: 21566766
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
39. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
40. Familial study of chronic lymphocytic leukemia: aggregation of different malignant processes in families with individuals affected with chronic lymphocytic leukemia.
Nenova IS; Karnolski IN; Mateva NG; Sotirova KN
Folia Med (Plovdiv); 2006; 48(1):11-6. PubMed ID: 16918049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
